Washington University urologists treating patients with advanced prostate cancer work closely with other specialists at the Alvin J. Siteman Cancer Center at Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital. This multi-disciplinary team may recommend surgery, radiation therapy or chemotherapy or a combination of these treatments. Clinical trials of new therapies for advanced prostate cancer are also available to appropriate patients through Siteman.
Gerald Andriole, MD, Division Chief of Urologic Surgery at Washington University School of Medicine in St. Louis, leads a new high-risk prostate cancer clinic at Christian Hospital. Dr. Andriole, the Robert Killian Royce Distinguished Professor and a 2020 Distinguished Faculty Award recipient at the School of Medicine, refers to this clinic’s treatment as a “CHARM Offensive” because it is dedicated to the Care of men who have High risk, Advanced, Recurrent or Metastatic prostate cancer.
When cancer is particularly aggressive or widespread, it takes a diligent team of expert physicians to provide the best, most comprehensive care. The high-risk prostate cancer clinic provides access to the full range of treatment options, including surgery, radiation, hormone therapy, chemotherapy, immunotherapy and cryoablation.
Care for patients with advanced prostate cancer is offered not only at the center in St. Louis, but also at the Siteman facility on the campus of Barnes-Jewish West County Hospital.
More information on prostate cancer treatment at Siteman Cancer Center.